Distinctive dendritic cell modulation by vitamin D3 and glucocorticoid pathways

Biochemical and Biophysical Research Communications

Volumn 297, Issue 3, 2002, Pages 645-652

  Xing, Nianzeng ^a   L Maldonado, Monica ^a   Bachman, Lori A ^a   McKean, David J ^a   Kumar, Rajiv ^a   Griffin, Matthew D ^a  

^a MAYO CLINIC   (United States)

Author keywords

Antigen presentation; Chemokines; Dendritic cells; Glucocorticoid; Immune responses; Interleukin 12; Nuclear factor B; Steroid hormones; T lymphocytes; Vitamin D

Indexed keywords

CALCITRIOL; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; COLECALCIFEROL; CYTOKINE; DEXAMETHASONE; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN; RANTES; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFECT; DRUG POTENCY; IMMUNOMODULATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; CELLS, CULTURED; CHEMOKINE CCL2; CHOLECALCIFEROL; CULTURE MEDIA, CONDITIONED; DENDRITIC CELLS; DEXAMETHASONE; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; MACROPHAGE INFLAMMATORY PROTEIN-1; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; RANTES; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, CHEMOKINE; T-LYMPHOCYTES;

EID: 0036387169     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02262-3     Document Type: Article

References (38)

1. J. Banchereau, R.M. Steinman, Dendritic cells and the control of immunity, Nature 392 (1998) 245-252.
2. S. Gallucci, M. Lolkema, P. Matzinger, Natural adjuvants: endogenous activators of dendritic cells, Nat. Med. 5 (1999) 1249-1255.
3. W.R. Heath, C. Kurts, J.F.A.P. Miller, F.R. Carbone, Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens, J. Exp. Med. 187 (1998) 1549-1553.
4. R.M. Steinman, S. Turley, I. Mellman, K. Inaba, The induction of tolerance by dendritic cells that have captured apoptotic cells, J. Exp. Med. 191 (2001) 411-416.
5. 3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation, J. Immunol. 164 (2000) 2405-2411.
6. 3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells, J. Immunol. 164 (2000) 4443-4451.
7. M.D. Griffin, W.H. Lutz, V.A. Phan, L.A. Bachman, D.J. McKean, R. Kumar, Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs, Biochem. Biophys. Res. Commun. 270 (2000) 701-708.
8. 3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo, Proc. Natl. Acad. Sci. USA 98 (2001) 6800-6805.
9. M. Moser, T. De Smedt, T. Sornasse, F. Tielemans, A.A. Chentoufi, E. Muraille, M. Van Mechelen, J. Urbain, O. Leo, Glucocorticoids down-regulate dendritic cell function in vitro and in vivo, Eur. J. Immunol. 25 (1995) 2818-2824.
10. L. Piemonti, P. Monti, P. Allavena, M. Sironi, L. Soldini, B.E. Leono, C. Socci, V. Di Carlo, Glucocorticoids affect human dendritic cell differentiation and maturation, J. Immunol. 162 (1999) 6473-6481.
11. A.M. Woltman, J.W. de Fijter, S.W. Kamerling, L.C. Paul, M.R. Daha, C. van Kooten, The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells, Eur. J. Immunol. 30 (2000) 1807-1812.
12. M.K. Matyszak, S. Citterio, M. Rescigno, P. Ricciardi-Castagnoli, Differential effects of corticosteroids during different stages of dendritic cell maturation, Eur. J. Immunol. 30 (2000) 1233-1242.
13. G. Jones, S.A. Strugnell, H.F. DeLuca, Current understanding of the molecular actions of vitamin D, Physiol. Rev. 78 (1998) 1193-1231.
14. L.I. McKay, J.A. Cidlowski, Molecular control of immune/inflammatory responses: interactions between nuclear factor-κB and steroid receptor-signaling pathways, Endocr. Rev. 20 (1999) 435-459.
15. W.Y. Almawi, D.A. Hess, M.J. Rieder, Multiplicity of glucocorticoid action in inhibiting allograft rejection, Cell Transplant. 7 (1998) 511-523.
16. 3 prevents insulitis in NOD mice, Diabetes 41 (1992) 1491-1495.
17. 3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis, Proc. Natl. Acad. Sci. USA 93(1996) 7861-7864.
18. 3, Eur. J. Immunol. 30 (2000) 498-508.
19. 3 and mycophenolate mofetil treatment mediate transplantation tolerance, J. Immunol. 167 (2001) 1945-1953.
20. N. Xing, Y. Chen, S.H. Mitchell, C.Y. Young, Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells, Carcinogenesis 22 (2001) 409-414.
21. S. Sozzani, P. Allavena, A. Vecchi, A. Mantovani, Chemokines and dendritic cell traffic, J. Clin. Immonol. 20 (2000) 151-160.
22. C. Caux, S. Ait-Yahia, K. Chemin, O. de Bouteiller, M.C. Dieu-Nosjean, B. Homey, C. Massacrier, B. Vanbervliet, A. Zlotnik, A. Vicari, Dendritic cell biology and regulation of dendritic cell trafficking by chemokines, Springer Semin. Immunopathol. 22 (2000) 345-369.
23. K.G. Steube, C. Meyer, H.G. Drexler, Constitutive protein expression of monocyte chemotactic protein-1 (MCP-1) by myelomonocytic cell lines and regulation of the secretion by anti- and pro-inflammatory stimuli, Leuk. Res. 23 (1999) 843-849.
24. D.A. Zisman, S.L. Kunkel, R.M. Strieter, W.C. Tsai, K. Bucknell, J. Wilkowski, T.J. Standiford, MCP-1 protects mice in lethal endotoxemia, J. Clin. Invest. 99 (1997) 2832-2836.
25. J. Pattison, P.J. Nelson, P. Huie, I. von Leuttichau, G. Farshid, R.K. Sibley, A.M. Krensky, RANTES chemokine expression in cell-mediated transplant rejection of the kidney, Lancet 343 (1994) 209-211.
26. P.J. Nelson, A.M. Krensky, Chemokines, chemokines receptors, and allograft rejection, Immunity 14 (2001) 377-386.
27. S. Ghosh, M.J. May, E.B. Kopp, NF-κB and Rel Proteins: evolutionarily conserved mediators of immune responses, Annu. Rev. Immunol. 16 (1998) 225-260.
28. G.J. Clark, S. Gunningham, A. Troy, S. Vuckovic, D.N. Hart, Expression of the Rel B transcription factor correlates with the activation of human dendritic cells, Immunology 98 (1999) 189-196.
29. M. Neumann, H. Fries, C. Scheicher, P. Keikavoussi, A. Kolb-Maurer, E. Brocker, E. Serfling, E. Kampgen, Differential expression of Rel/NF-κB and octamer factors is a hallmark of the generation and maturation of dendritic cells, Blood 95 (2000) 277-285.
30. + dendritic cells by specifically inducing p35 gene transcription, J. Exp. Med. 194 (2001) 1021-1031.
31. R.I. Scheinman, P.C. Cogswell, A.K. Lofquist, A.S. Baldwin Jr., Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids, Science 270 (1995) 283-286.
32. N. Auphan, J.A. DiDonato, C. Rosette, A. Helmberg, M. Karin, Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis, Science 270 (1995) 286-290.
33. 3, Proc. Natl. Acad. Sci. USA 92 (1995) 10990-10994.
34. D. D'Ambrosio, M. Cippitelli, M.G. Cocciolo, D. Mazzeo, P. Di Lucia, R. Lang, F. Sinigaglia, P. Panina-Bordignon, Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-κB downregulation in transcriptional repression of the p40 gene, J. Clin. Invest. 101 (1998) 252-262.
35. K. De Bosscher, W. Vanden Berghe, L. Vermeulen, S. Plaisance, E. Boone, G. Haegeman, Glucocorticoids repress NF-κB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell, Proc. Natl. Acad. Sci. USA 97 (2000) 3919-3924.
36. A. Verstuyf, S. Segaert, L. Verlinden, K. Casteels, R. Bouillon, C. Mathieu, Recent developments in the use of vitamin D analogues, Curr. Opin. Nephrol. Hypertens. 7 (1998) 397-403.
37. H.F. DeLuca, M.T. Cantorna, Vitamin D: its role and uses in immunology, FASEB J. 15 (2001) 2579-2585.
38. F.J. Barat, D.J. Cua, A. Boonstra, D.F. Richards, C. Crain, H.F. Savelkoul, R. de Waal-Malefyt, R.L. Coffman, C.M. Hawrylowicz, A. O'Garra, In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines, J. Exp. Med. 195 (2002) 603-616.